Council for Tobacco Research
Report of the Council for Tobacco Research, U.S.A., Inc. [St]
Fields
- Depository Date
- 25 Sep 1995
- Master ID
- Ctrmn00010849-2859
Related Documents:- CTRMN010849-0887 Deposition of Lorraine Pollice [Deposition of Pollice in the Matter of Allgood]
- CTRMN010888-0889 Scientific Advisory Board Members 1954- [Record of Names of Members]
- CTRMN010890-0892 Curriculum Vitae [St]
- CTRMN010893-0919 Curriculum Vitae [St]
- CTRMN010920-0926 [St]
- CTRMN010927-0938 Curriculum Vitae [St]
- CTRMN010939-0956 Curriculum Vitae [St]
- CTRMN010957-0958 Curriculum Vitae of Dr. Mckeen Cattell [St]
- CTRMN010959-0960 Curriculum Vitae of Dr. Julius E. Comroe Jr. [St]
- CTRMN010961-0974 Curriculum Vitae [St]
- CTRMN010975-0990 Abstracts [St]
- CTRMN010991-1010 [St]
- CTRMN011011-1020 Curriculum Vitae [St]
- CTRMN011021-1056 Curriculum Vitae [St]
- CTRMN011057-1082 Jeffrey Robert Idle Curriculum Vitae [St]
- CTRMN011083-1092 Leon Orris Jacobson, M.D. [St]
- CTRMN011093-1116 Curriculum Vitae [St]
- CTRMN011117-1123 Curriculum Vitae [St]
- CTRMN011124-1126 Curriculum Vitae of Dr. Paul Kotin [St]
- CTRMN011127-1128 Curriculum Vitae of Dr. Clarence Cook Little [St]
- CTRMN011129-1132 Biographical Sketch [St]
- CTRMN011133-1160 Curriculum Vitae [St]
- CTRMN011161-1161 Ctr Mn 011161 Is Unused [Record of Bates Number]
- CTRMN011162-1163 Curriculum Vitae of Dr. Kenneth Merrill Lynch [St]
- CTRMN011164-1166 Curriculum Vitae [St]
- CTRMN011167-1176 Curriculum Vitae Gordon Barry Pierce, Jr., M.D. [St]
- CTRMN011177-1178 Curriculum Vitae of Dr. Stanely Philip Reimann [St]
- CTRMN011179-1180 Curriculum Vitae of Dr. William Francis Rienhoff Jr. [St]
- CTRMN011181-1190 Curriculum Vitae of Gordon Sato [St]
- CTRMN011191-1219 Curriculum Vitae [St]
- CTRMN011220-1239 Curriculum Vitae [St]
- CTRMN011240-1241 Biographical Sketch [St]
- CTRMN011242-1243 Curriculum Vitae of Dr. Edwin Bidwell Wilson [St]
- CTRMN011244-1245 Curriculum Vitae [St]
- CTRMN011246-1274 1956 Report of the Scientific Director [St]
- CTRMN011275-1325 Report of the Scientific Director [St]
- CTRMN011326-1359 1958 Report of the Scientific Director [St]
- CTRMN011360-1396 1959 Report of the Scientific Director [St]
- CTRMN011397-1430 1960 Report of the Scientific Director [St]
- CTRMN011431-1467 1961 Report of the Scientific Director [St]
- CTRMN011468-1499 1962 Report of the Scientific Director [St]
- CTRMN011500-1500 Ctr Mn 011500 Is Unused [Record of Bates Number]
- CTRMN011501-1535 Annual Report of the Scientific Director [St]
- CTRMN011536-1576 Report of the Scientific Director [St]
- CTRMN011577-1619 Report of the Scientific Director [St]
- CTRMN011620-1662 Annual Report of the Scientific Director [St]
- CTRMN011663-1720 Annual Report of the Scientific Director [St]
- CTRMN011721-1765 Report of the Scientific Director [St]
- CTRMN011766-1815 Annual Report of the Council for Tobacco Research U.S.A, Inc. [St]
- CTRMN011816-1870 Report of the Council for Tobacco Research - U.S.A., Inc. 1972 [St]
- CTRMN011871-1871 Ctr Mn 011871 Is Unused [Record of Bates Number]
- CTRMN011872-1921 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN011922-1968 Report of the Council for Tobacco Research, U.S.A., Inc. [St]
- CTRMN011969-2011 1975 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012012-2057 1976 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012058-2101 1977 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012157-2210 1979 Report of the Council for Tobacco Research - U.S.A, Inc. [St]
- CTRMN012211-2211 Ctr Mn 012211 Is Unused [Record of Bates Number]
- CTRMN012212-2268 1980 Report of the Council for Tobacco Research - U.S.A, Inc. [St]
- CTRMN012269-2329 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012330-2386 1982 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012387-2458 1983 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012459-2533 1984 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012534-2534 Ctr Mn 012534 Is Unused [Record of Bates Number]
- CTRMN012535-2647 1985 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012648-2744 1986 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012745-2844 1987 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012845-2859 Partial Listing of Research Institutions, Ctr Grantees at Those Institutions, and Dates the Grantee Received Ctr Funding at That Institution [St]
- Author
- Ctr
- Request
- 118
- Type
- ANNUAL REPORT
- Box
- 006
- UCSF Legacy ID
- ovr30a00
Document Images
ANOREWS urFICE PRODUCTS CAPITOL HEIGHTS, MO (K)

CTR t iN 0 12103

rf,,.!
~ ~'; i i
'. i . . .~s
!
:
. r
- ' 1
}
.
.
t
. .
f
1 `
, . .r t.
I
'.
y~
^
-
~ `
c
.
~
! ~
~
!
_
/ !
~
0 r
r:. .
.vP...
~~'2
kOxgan~a~~,~.Q~ ,~_..;
. 1v!( j
w {
,
i ~
'=. . .' ' ~ .
'
.
,
, ' .. . ~
`
Canoc11 for Teb.oop luW".3.A., l.o, i. tlr .pee0ori.l. .{coeT
.. ~,
t~ as peo=r...[ eese.cb i.a auatb.. K tob.oeo w sd re.hb. It I. tbe out-; '
ot .r orp.dueio, toee.e ..r11r (. 1934 y weuooo ..eut:.cwrea,
1>
`
'
.
u-
IPpws :LO wpre6ovessuca Rsss.esli Mwpwt 1m bw to.Wf t4ou9b a pr
~a.m of r.MFlt.id wwppkby owftauref t0a.r+.a.rcb with IrtMuwloir
,.. ~
r;'1 W.e fso..wr1... Te. Cwedl eo...o1 qaIN pq~r.ftrd ld!Ity.
,' ,. Sd.& {c AA.rory ewrd b 71. Ooiit:l~rniM R~f to .nin.M` ~ } t
i
rMlAQ ti ~ t
~pi~l (t }d~ {!p~ ~~11 OrMt of 1c
toe.or r..e.rtb qppor,i .-_ %.
T1. Couac~ ,w.rds tMe.relt ' a i~4epi!dwd ~drttw w.a rn .~ 1yr ~r
fitr.e oompl.b .deoU6o treeeoa, a~et~ ,ltar ,N,dlr, ur.aaea .lo.. 3
~~~~~
~:}~ ft04 00f~ cor Ilport~0` or pY.+.~~~ twr SsIO/ r 11N sOOOpW KjN ,,,
.`q~o :..e... ~ tlirougb meak,l .va aim{feo joarud..na .odal«. -
,A; :Ttirougb DeoemUer 1978 Ths CauecY .pprored reae.rcA pro%.ct. Ior 379
4}wr.dt.ton I. 247 te.dical .cbool., bo.plt.l..od re.earc6 4rtputioa.. Tbai.
IMab Iot.M+ Aa. t6~o ss 1.900.000.
'
' sd p.eriar re.e.rclt proIecb .up
T°b R'*°`1 hVtl~dp lirlr ol aures/
d 1- 'TA. Covecil. Also IeeltadeA ~r. .b.tr.etm ot 114 «ae.rc p.pen.
. ~ . L-g -
-Uwb.d 1. Fkatiec laun.la dar-
t
dl
p
.
wippor
r . .~kapald~i.~ Cou.
j9S 19711 Prvject reclpkeb hnr. a~r ~bWa i.¢21 .ucs p.pcn.
AtiouoN Yaww
Ci.has .od Prnide.l
. !
!1!i
l .
m
Ln
~
m
a
,
1978 REPORT
o/
THE COUNCIL FOR TOBACCO RESEARCN-U.3.A., lee.
TIIE COUN(:11. FOR TORA(:/:1/ RFtit:AR('ll-tl.'i.A., lee.
110 F...1 S9d. Street, New York, N.Y. 10022

SCIENTIFIC ADVISORY BOARD
to The Council for Tobacco Research-U.S.A., Inc.
as of December 31, 197R
SHELDON C. SOMMERS, M.D., Chalrtnms
Direcw of [.aboratorles. Ltoos HiU Hospital
Clinkal Professor of Pathobp
Colk~e of Physkiana fc Sutgeorr o( Columbia University
New York, New York
RICHARD ). BINO, M.D.
Director of Cardiology and lnt. snard MrdkJne
Huntington Memorial Hoapitd, Pasadena, California
Pro/essor of Medicine
University of Southern California School of Medicine
Los Angele., California
JOSEPH D. FELDMAN. M.D.
Read, Department of Immunopathology
Scripp~ Ctink and Research Foundatbn
La )olla, California
WILLIAM U. OARDNf'R. Pw D.
Sclenti/ic Director. The Council for Tobacco Research-tI.S.A , Inc.
E. K. Nunt Pro/essor of Anauny (rnuritur)
Yak University Schocd of Medicioe
New Haven, Connecticut
ROBERT J. HUEBNER, M.D.
Chief. Laboratory of RNA Tumor Viruses
National Cancer Institute
Betheada, Maryland
LEON O. IACOBSON, M.D.
Joseph Regenste(n Pro(rstor of Biolotkal Scirnces
Unive of Chicaso
Chkago, Wnoia
HENRY T. LYNCH. M.D.
Professor and Chairman
I
Department of Preventive Medicine and Public Health
0eighton llniveraty School of Medicine
Onaha, Nrt'rarka
t
HANS MEIER, D.V.M., Dr. Med. Vet., M.R.S.II.
Senior Staff Scientist
The Jackson Laboratory
Bar Harbor, Maine
LEE W. WATTENBERG, M.D.
Professor of Pathology
Department of Laboratory Medicine and Pathology
Umversity of Minnesota Medical School
Minneapoli., Minnesota
JOHN P. WYATT, M.D.
Director
Tobacco and Health Research lnatilute
University of Kentucky
Lexington. Kentucky
Sdenliie Staff of 7Ue Ceuneil
WILLIAM U. GARDNER, Pw.D.
SdenH/ic Director
ROBERT C. HOCKE7T, PH.D.
Resewrh Director
DONALD tl. FORD. P41.D. VINCENT F. LISANT7, D.M.D.
Associate Research Director Astoclate Research Director
DAVID STONE. PH.D.
Associate Research Director
,

CONTENTS
Introduction . . . . . . . . . . . . . . . .
Abstracts o[ Reports .
Cancer-Related Studies . . . . . . . . . . .
The Respiratory System . . . . . . . . . .
1leart and Circulation . . . . . . . . . . .
Neurophannacolo6y and Physioloq . . . . . . .
Pharmaeolosy and Biochemistry . . . . . . . .
Immunology and Adaptive Mechanisma . . . . .
Epidemiology . . . . . . . . . . . . . .
Active Projects .
Completed Projects . . . . . . . . . . . . . .
lode: of Principal Investisaton . . . . . . . . . .
lodes of Seoior Authors . . . . . . . . . . . . .
. 5
. 7
. . 7
. . 26
41
. . 49
. . 62
. . 70
. . 77
. . 83
. . 92
. . 103
. . 104
I
' Introduction
This report m.riu the completion of 25 years is which 7b Council for
Tobacco Research has supported a program that has bewrne sb" world's mosl
extensive noa-governmeatal research effort rekvaet Io smokins and health.
When The Council was estaMished in 1931, it adopted a basic policy that
has been followed without deviation: to pl.ce responsibility for research policy
and programming in the hands of a Scientific Advisory Bo.rd and to have 1ho
research conducted by independent investiplon in tht3r own lnstitutions with
so striop attached.
Up to the end of 1978, the program has resulled in the publication of
1.622 reports and articles that acknowledged Council support. 77rua, the pro-
gram has produced considerable data related /o smoking and health during a
periud Ibat also saw Ihe generation of oomiderable eoMroveny and unotior
about the subpct.
No one can fully predict at this time what these publications will meau
in the search for the answers b the problem of the major, a8ing-.»ocialed
and constitutional diseases of eancer, heart disease and chronic pu4aoa.ry
ailments. However, the hope is that some day the Andinp from one or mrore
studies may provide keys or links for a major biomedieal advance.
The Council eaisu today because the complex etiology of these oonslitu-
tional diseases remains unraveled. These diseases have been associated ststiL-
tically with amoking, but such a»ociations are not proof of cause and effect.
The diseases are extremely complex-cancer itself, for eaampk, b siol os
disease but many-and /indin8lheir causes will not be easy.
The overall importance of genetic faelors is being increasingly reco8nired,
accepted and studied. Progress is being rwade, but it is necessarily slow sad
painstaking.
The statement of many years ago that we live in a "sea of careLa{ear'
is supported by nmch recent and current research. Many Ihin8l--both natural
and man-made-that we ea1, drink and breathe have been implicated (n canoer
and heart disease, at least in laboratory eaperimenls. But exact proof, proof
that meets scientific criteria, is often lacking.
Whatever contribution lo scientific knowledge that may be attributed to
The Council's program, as evidenced in part by the numerous reports in the
Gterature, is due principally to the members of the Scientific Advisory Board,
p.st and present. 7lrese scienliMs, who have always maintained their inuilo-
Iiond alfiliations, have given unsdOshty of their time and talents. 'i'he result
of their combined cRort lor so many years is an Imaginalive undertaking that
has enabled many reaearchen to pursue ideas and theories that might other-
wise have gone une.p{ored for lack of support.
lbe Council is gratified at the response through the years of Ihe sckn-
tists who have applied to it for research support. 'Ibis intereat remained high
in 1978 aand the number of requesu for support of new and continuing re-
search assures a worthy future.
7 his report contains abstracts of research findings published in 197 that
aCkMtwtrdeted ('ouncd sponsorship. As can be aeen. Ihe major em~hasis c.xr-
linucs to be directed loward cancer, the cardiova+colar system and Ihe respira-
3

tory tract. The abstracts of the published papers are indicative of the areas of
research supported by llre Council.
lhe Council looka back with utisfaclion at what has been accomplished
in the lasl quarter-century. It looks to the future with optimism and hope for
research that will help sdve the mysleria of canter, heart disease and chronic
pulmonary ailments. The Council pkdgea to continue its support of inde-
pendent investigators in their effotts to add to scieotific knowledge related to
smoking and health.
I
1. ('.awcer-Relwted Studies
Abstracts of Reports
Following re ab.trac/s, approved by the aulhors, of reporu oo .ew
research acknowkdging wpport front TLe Council that have appeared in acka-
tifk journals since publication of the 1977 Report. The name of Ihe recipieM
is in iulica.
The abstracts are grouped under these headings: 1. Cancer-Related Studia,
(1. lhe Respiratory System, 111. Neart and Circulation, IV. Neuropharmacubpr
and Physioloty, V. Pharmacology and Biochemistry, VI. Immunobp aad
Adaptive Mechanwns, VII. Epidemiology.
CRITERIA FOR Se1.ECi1NO CHEMICAL COMPOUNDS FOR
CARCINOGENICITY TFSfINO: AN ESSAY
The ever increasing number of organic compounds conslantly being bstra
duced into the various aegmenls of the wrorldwide economy cnrales 1he aeed
b devise a formal scheme of selection criteria for testing of suspectod car-
cinogens, and to establish priorities /or auch testinll. Four caleitoriea of erileria
must be considered: (1) structural. (2) operation.l, (3) "guilt by arocia-
tiwr," and (4) "after the fact." This essay Rives an analytic discussion of each
of these criteria. Structurd criteria are deduced from a=eneral perspective of
the structure-activity relalionship of known earcitsoRens. The operalional erih
teria, which are complementary lo the structural ones, represent the sum of
the bio-/unctional capabilities of chemical compounds. These capabilities oor-
relate with the ability to induce malignancy lhroukh such mcchanisma as, for
eaampk, mulajenicily, induction of DNA repair, and Mnmuno.uppression. The
"guilt by association" criterion alates that a compound belonging to a chem-
ical clase already known to contain several other compounds eslablished as
potent and mullilarilet carcinogens should be 1esled under more stringent con-
ditions than those of the standard bioasay. The "atter the fact" criterion
deAnes previous epidemiologie indications as the basis lor selecting certain
chemical agents /or carcinogenicity tesling. The overall significance of Ihe
bioassay dala obtained on individu.l eompounds, however, should be ea+-
sidered in conjunction wilh other endogenous ud eaoaenous interacting lac-
tors such as: /1) synergistic and anlakonistic sKtivoy between multiple car-
einokenie agents; (2) dlects of nonc.rcinotenk environmental agents on
carcinogenic activity; and (3) viru.es, nusrition, radiation, age, stress, endo-
erine bdanee and th, state of th. (rnnwne wrveillance system. 'fln huae
number of akenu and facton, their interactions and the coesidence of fre-
quently conflicting societal soala, indicate the seed for the establishment of
versatile acientificoletal standards and guidelines applicable to eatetoria sarl
types of chemical agents rather Ihan to individual eompounda. ~
/rror, l. C.
~
lorrnd of Ewrironm.nrd laholosy ad Toakoloty 1:1))-ISe, 1978.
7'
6

OtRer aupportr National Cancer Imtilute.
From the Seamen's Memorial Research Iaboratory, U. S. Public )ler,lth Service
Ilospilal, New Orkana; and the Department of Mcdicioe. Tular c Medical
Center. New Orleans.
UI:1 RASTRU(`Tl1RAL AND METABOLIC DETERMINANTS OP
RINISI'ANCE TO AZO-DYE AND SUSCEPTIBILITY TO
NI1 ROSAMINE CARCIN(7GENPSIS OF THE GUINEA-PIO
The a:o dye rcductase and nilroaamine dealkylaae activities of normal
guinea-pigs and rala were compared b those of animals fed ar.o dye and
niuo.amine. Electron microscopy reveakd ultraalruetur.l alkralions of the
guinea pig liver during nilrosamine administration. Dielhylnitrosamine (1)EN)-
induced hepatic lumot cells showed extensive proliferalioo of the rough endo-
plasmic reticulum ( ER ), while the smooth ER wat quite tp.rx; the opposite
was true in the prema)ignanl liver. In the rnt, however, administration of
either DEN or Y-methy/-Idimelhylaminoa:obtnzene (Y-Me-DAB) caused
prolderatioe of the smooth ER and sparsity of the tough ER in both pre-
malrgnanl and malignant tissue. In both specin, the number of ribosomes on
the outer surface of Ihe liver rough PR was greatly reduced as was the RNA/
protein ralio, which correlated with a decreased r+eaponse to an Slt probe
In nmicroaomal suspensions A:o dye reduclase activity was higher in untreated
rats than in untreated guinea pigs. After sit weeks of T-Me-DAB feeding,
however, this was 76% lower in the ral while there was no significant decrease
in the guinea pig, which is refractory to azo dye carcinotenesis. 77sus, as in-
geslinn approached the lumorigenic threshold doae. the rat liver's ability to
inactivale the dye was much impaired, but not that of the guinea pig. Control
levels of ni/rosamine dealkylase were idenlical in both apeeies, however, and
remained essentially unchanged Iter 10 weeks of DEN adminislration. Since
nitro.amine dealkylation represents activating metabolism. this provides the
basis for the idenlical susceptrbililies of the rat and the guinea pig to DEN
carcinotte.rcsis. Of the two enzymes eaamined, only Ihe guinea pig azo dye
reduclase appean to be independent of glucose repreaion, since its activity
was unchanged by starvation. Statvalion-irduoed elevation of azo dye reduclne
activity in the rat was not affected by Y-Me-DAB administration and only
slightly influenced by DEN In both specks, however. DEN abolished the
aarvation-induced increase of nilro.amine dealkylation, while )'-Me-DAB
decreased it only slightly.
Bryant. (i. M., Sohal, R. S., Arpn, M. P., and Arcos. l. C.
drittrA Joucwd of Cancer 76:676-691, 1977.
Other .u pport ) National Cancer Institute.
Prom the Department of Mcdicine, Tulane Medical Center and Seamen:
Mernorr.J Kcseaah I aN.ua1ry, 11 S Public Ilcalth Service llolpilal, New
Ur1c..ns,..uJ Ihc Ikp.rrotcnt of Itwhity, SanUhcrn Melhodnl llurverslty,
1).IL1.
I
IiYDROCARBOMNrI'ROSAMINE PULMONARY SYNCARCINO-
GEN['SIS: RI:CIPROCAL EFFECTS ON METABOLISM
This study reports on the entynqlogical correlates of the pulmonary ayn-
carcinogenesis which h.a been observed between melhykholanthreoe (MC)
and dimethylnitrosamine (DMN) following acute administration of the car-
cinotenr. E.perimenlally, .ryl hydrocarbon hydroaylase (AHH), eposide
hydrase. DMNdemelhylase, and ilIvlalhione-S<potide Irana/eraae activities
were studied in the liver and lung of DBA/21 and C378V61 mice. two atraiaa
which are, respeclively, noninducibk and inducible for hepatic A1111. Change
in theae enzyme activities was determined following acute adminislralioa of
MC. DMN, and their combinations. In the liver-eacepl tor a.ubstantial ie-
duction of hepatic Atilt in the C37B1./61 alrain-1he metabolic pattern is
very similar in the two strains. In both slrairr DMNdemelhylase ia highly
sen.utive to DMN prelrcatment at the aia mg/tti level. Increase of DMN to
the total syncarcinogenic dose of 60 ms/kil abolishes induced AIIH in the
C37B1./61 and brings about substantial inhibition of aB other en:ymea studied.
In the lung of the two alrains, induced Atilt was found to be highly aensitive
to DMN pretreatment in the DBA/2J, and DMN-demelhylaae 11 (the only
DMN-demethylse present in the lung) was substantially reduced following
Prelrealment with 60 mg but not with 6 mg DMN. Tlse most interesting re-
sulls in the lung are .een with the C37BL/61 strain since, with 60 mg DMN/
tg, there is a substantial decrease of the epoaide hydrase together with a
substantial increase of the AIIN. This suggests a mechaniatic interpretatiom
of the Atilt increase within the framework of the known palhways of hydro-
carbon metabolism and a greater suaceplibilNy of the C378t./61 strain to Ur
combined administration of MC and DMN.
Arcoi, J. C. d at.
In: Gelboin, II. V. and T: o, P. O. P. (eds. ): rotpcycflc Hrdrocarbowr md
Cancer--Environnrent, Chemistry and Alttaboll.ns, New York: Academic
Press, 1979. vol. 1, pp. 271-282.
From Tulane University School of Medicine, New Orkana.
DIPFP.RENTIAI. EFFECTS OF a-NAPTHOFLAVONE AND
PREGNENOLONE-16a1:ARBONITRILE ON DIMETIIYI.NITItO-
SAMINN-INI)ll('I:D IIEPATOCARCINOGENFSIS
7he carcinogenicity of dimethylnilroaamine (DMN) is inhibited by the
co-administratiun of either 7-melbykholanthrene or anminoacelonitrik, com-
pounds which substantially lower the activity of DMN-demcthyla/e, a micro-
somal mi.ed-lunction oaidase that catalyzes the activation of DMN. In the
present investigation imed at elucidating further this correlalion, the eRect
of administering jil-naphthoflavone (0-NF) and pregnenolone-16.-carbonitrile
(PCN) on the hepatocarcinotenicity of DMN in male SD rata wa%* explored.
Bo1h /! NI: and 1'('N are potent represson of the bw-Michaeliu-conslant en-
:ymalic form of 1)MN demethylase. Ncpalie tumors were found in every
group of rats receiving DMN alone or in combination with A NP or PCN.
8 9

I
I
I
a
The morphology of these tumors waa quite similar for all three kroups, with
3396 of the 53 liver tumors observed being angiosarcomu. DMN-induced
bepalocarcirw6enenis was partially inhibited by PCN and enhanced by P-NP.
Seven liver turnors were found in 45 rats fed DMN plus PCN compared to
32 liver tumon in 43 rats fed DMN plus aNF; 14 liver lumon wrre found
in 43 rats fed DMN abne. No liver tumon were detected in rats that received
only PCN, /f-NF, or Ifse administration reAicks. The unespected enhancement
of DMN Induced carcinokenesis by aNP prompts a reexaminatwrn of the
presently accepted activation mechanism of DMN.
Argu., M. F., Hoch-l.igeli, C., Arsor, !. C., and Conney, A. H.
/orrnal o/ the Narional Cancer Iwsrhr/e 61(2) :441-449, 1978.
O1Mr arpportlt National Cancer Institute.
From Ihe Seamen's Memorial Research Iaboratory, 11. S. Public Hcalth Service
llospital, and the Department of Mediclne, Tulane University School of
Medicine. New Orkans.
USE OF HInH CONCENTRATIONS OP DIMETHYLNI71tOSAMINE IN
SACI-I!RIAI. LEl HAI-1 fY, MUTAOENpSIS. AND flNZYMOL(X)ICAL
STUI)I PS
Previous studies have established that the potency of dimethylnilro.amine
and dielhylnitrosamine in bringing about conformational changes in protein
is comparable to that of urea and kuanidinium chbride, well-known protein-
denaturing agents. In addition, an optical rotatory dispersion study of the
ovaR>tunin conformalional change as a function of dimelhylni/rosamine coo-
centration had indicated a concentrationdependent ambivalent effect on pro-
tein conformation. Thus, at concentrations of, and greater than, about 200
mM, dimelbylnitrosamine brinp about denaturation. However, a1 concentrr
tioro from 200 mM downward the b, constant of ovalbumin increases with the
decrease of dimethylnitrosamine concenlratioe, suggesting Ihat, in this oon-
eeotratioa ne6e, dimelhylnilroaamine bas a refolding ('Yightenink`) rather thae
unfolding (denaturing) effect on the protein eecondary structure. 8ecause of
ita protein-denaturing ability, dimethylnitrownine at high concentrations can
bring about cell death. In eonlrast, when 20 to 200 mM dimethylnitrosamine
is used in esayme and mutagenesis awys, because of its re(olding cffect on
protein secondary slructure at thne ooecentrNions, il may produce a1Mtileric
enzyme eonformational changes iw vhro, thereby possibly creating artiiactual
phenomena. Indeed, the use of nonpharmaeologically high eoncentrations of
dinxthylnitroaamine and diethylnhrosamine appears to be the basis of con-
flicting reports on the repressibility versus inducibility of dimethylnitrosamine
demethylase and diethylnilrosamine declhylase and on the effect of enzyme
indu.er prctre.lment on ndro.amine mulagenicily activation by microsnmes.
keaenr onvesrrpu.a.s sugaeN rhst the apparent confbct is due to the eslsrence
ot h.o rnlymK /orme o/ dinuthylmuosamine demerhylase that rc%porwl in
duiuctn,.11r opt.vu +ass (n.mely, repreasn+n and mdutthun) ts- cnryme
in,tu.cr plctrratmrnt Il.r.r ot.xrvahuns and othcrs kad the aulhuu so con-
10
I
clude that the cortfentration of dimethylnitrosamine (or any other nilrosamin.)
uud in In vitro assays should be kept under 20 mM, and preferably below
5 mM. Since the purpose of studying the melabdism, mutagenicily, and cellu-
lar effects of dimelhylnilrosamine and other nilroumina Is principally to pia
insight into the mechanism of their carcinogenic eRecl, physiologically realistic
testing levels should be observed.
Argu., M. F. and Arcof, l. C.
Cancer RriearcYt 3t:226-22t1, 1978.
From the Seamen's Memorial Reseanch Lboratory, U. S. Public Health Servlo.
Ho.pital, and the Department of Medicine, Tulasse Medical Center, New
('rkans.
TISSUE AND SUBCELLULAR DISTRIBUTION OF a11-DIOXANC IN
THE RAT AND APPARENT LACK OF MICROSOME.CATALYZPd)
COVALENT BINDING IN THE TARGET TISSUE
Diosane, a commonly used induqrial and laboratory aolvent, lua bees
known to eahibil both bxic and carcinogenic activity. As part of a series of
investigations aimed at elucidating the mechanism of these eRecN, this paper
presents data on the distribution of 01l-dioaane among a number of rat tis-
sues and various wbcellular (ractions of rat liver. At various times dter
intraperitoneal injection. d'aaane was distributed more or less uniformly
among varqus tissues (liver, kidney, spken, hrng, eobn, and skeletal musck),
which is consistent with iu polar/nonpolar nature. llowever, in eoMraN so
this nearly uniform distribution, uudies of the nature of binding revealed larp
tisxre differences. Ttre liver (the main target of careinogenesi.), colon (de-
acending segment), and apken showed a greater amount of "eovaknl" binding
as measured by Ihe incorporalion of radioactivity Into lipid-free, acid-insoluble
materials. Much kss "covalent" binding occurred in the skeletal muscle and
blood. Investigations of the aubcellular distribution in Uver Indicated that moN
of Ihe radioactivity was in Ihe ey/osol, followed by the microsonul, mito-
chondriat, and nuckar /ractions. The binding of dio.ano lo the macromole-
cuks in the cytosol was mainly noncovaknl. The percent covalent binding
was highest in the nuclear (raclion, followed by milochondrial and mkrosornal
fractions and the whole hotnossenale. Pretreatment of rals wilh inducen of
mkrosomal mi.ed function olidasa had no aignifkant effect on Ihe covalent
binding of diosane Io the various subcellular fractions of Ihe liver. 7lrere is
no micrr>M>toetatalyred /w vitro binding of diosane to DNA under conditions
in ..hich there is ulensive bindinrof benro(a)pyrene.
Woo, Y-T., Arrus, M. F. and Arcos. 1. C.
LI/e Sciences 21(10) :1447-1436, 1977.
Olhtr support: National Cancer Inslitute.
From the Seamen's Memorial Research I aboralory, I1. S. Public Ileaith Senkaa
Ilosprul, and Ihe Department of Medi.cine, Tulane Univenily, New (bkaos
II

STRUCTIIRAL IDP.NTIFICATION OF p-DIOXANE-2-ONI3 AS 719@
MAJOR URINARY Mt'TABOLITE OF pD1OXANE
Intensive diosane eaposure causes severe liver and kidoey daroage and
even death. The compound is also a hepatie carcinogen in rata. In 1.lis inves-
ligation of the In viro metabolism of diosane, gas chromatography ((iC) of
the volatile compounds present In the urine of rats administered dumane re-
vesled a maior metaholile. The latter was detectable only at low 1 N kveA,
and the amount escreted was bo1A dose- aod /ime-dependent, reachin,: a maai-
mum 20 to 28 hours after intraperiloseal intectioo of dioxsne. Administration
of diethykne glycol produced the sarns metabdite, but mostly withir, the Brst
16 houn, suggesting that this compound may be an intermediate in the iw
viro metaholism of dioaane. Under similar eorditions, ethylene g!ycol, di-
glycolic acid and osalic acid did not induce escrelion of the metabolite. The
isolated and purifkd melslwlite displayed an intense carbonyl band at 1,750
em-' In the Infrared (IR) spectrum. Its nuclear marnctic resonance (NMR)
spectrum indicated two Iripkts and one singlet of equal Intensity at 1.81. 4.42
and 1)7, respectively. Upon GC-mass speclropholomelrie sludiq, there was
a parent peak at m/e 102. The nsetabolite wY idenlified u p-0toRSne-2-ooe,
as conflrmed by comparison to ita synthetie reference eompound, .rhich ea-
hibiled the same IR. NMR, and GC-masa spectra as the unknown. A tenla-
live metabolic pathway for diosane is presented; micraaornal mixed function
oaidases appear to be involved in this pathway. Preliminary eaperim:nl/ indi-
eate that the melaholite is considerably more toxic than the parent compound.
Its potential health hazard remains to be asaessed, espeeially since it is used
as a commercial and industrial preservative.
Woo, Y-T, Arcoi, l C'., Argus. M. F.. Gri/fin, 0 W., and Nishiyama, K.
Nounyn :jchmlcdtbrrt i Arrhivct o/ P.rrAoloeY 299.2N )-287, 1977.
Other supportt National ('ancer Institute
From the Seamen's Memorial Research I ahnrstory, I/ S Public Ilealth Service
Ilospilal; the Department of Medicine, Tulsne Universily; and the fkpartment
of Chemis/ry. University of New Orkans, New Orleans.
EFFI?fT OF MIXED-Fl1N(TION OXIDASE MOI)1f7F.RS ON
MNTABO1 ISM AND IOXICI CY U1' 1118 ONC(Xil?N 1)IOXANH
The effect of inducers and inhibilon of mised functie.n oxidases (MFO's)
on Ihe in riro rnetabolism of dio.anc in the rat was sludicd with both non-
radioactive and "('-labekd dioxane. In addition, the effects of various inducen
on the acute tosicily of diosane and Its principal urinary molaholite, p diosane-
2-one, were eaamined in an attempt to elucidate the relationship between the
mr1alm.lism snd lo.icily of this communly used udvcnt. Resulls showed that
prc/rcatment of mate 1praRue 1)awlcy r.ls with the itmhrcen phcrK+barlrild
(1'11). h1lyrhln11n.trd h1l1hrnyk /P('111, uN1, to a ntuch ksser eslent, )-
I
rnelhykholanthrene (MC), increased the metabolite escretion and shortened
the lime of onset W peak eacrelion of the metabolile. On the other hand, aa
Inhibitor or repressor of MFO's, such as either 2,1-dichloro-6-phenylphenoay-
elhylamine or cobapous chloride, decreased Ihe metabolite e.crelion. lbese ra
suhs subatantiate the invdvement of MFO's in the /n rlro me/abolism of
dioaane. When the relNionship between the metabolism and the acvte toxicity
of dioaane was espbred, il was seen that pdiosane-2-ene was considerably
more toxic than dioxane. The acute toxicity studies showed an apparent
t:orrelation between the metabolism and bsicity of dioxane in PCd- or MG
pretrealed rats. However. PB pretreatment had no effect on toxicity In spite
of substantially increasing dioaane i melabolism to p-dioaane-2one. Since Ibis
lack of PB effect Indicates that p-diosane-2one requires further metabolism
to exert ils toxic effecl, the totality of Ihese rewlls auggesls that the generation
of the toaic substance from dioxane may Involve a multistep mechanism with
pdio.ane-2one serving as an intermediate.
Woo, Y-T., Argus, M. P. and Arcos, 1. C.
Cancrr Research Je:1621-1623, 1978.
Other su pport t National Cancer Institute.
From the Seamen: Memorial Research Ldwralory, U. S. Public Neallh Servk.
Nospital, and the Department of Medicine, Tulane University Medical Cenler,
New Orkan..
RAfNOACTIVE ASSAY FOR ARYI. HYDROCARBON IIYDROXYLASE.
IMPROVF.D METIIOD AND BIOLOGICAL IMPORTANCE
This report describes an Isotopic AH/I assay, which meawres atl 1he
snelahoiites formed during the /n vitro inarhalion of various tissues (liver,
in/esline, lung, kidney) with (sN)-ben:o(.)pyrene and accurately determines
lower enzymatic activities such as those found in the lung or kidney. TAe
addition of Iwo volumes of a IM aqueous KOll/dimenhylsolfoaide (1!/8J;
v/v) mixture to the enzymatic incubation medium, makes it possible to aetec-
lively extract the unmclabolind benzo(a)pyrene in he.ane. Thus. the radio-
activity remaining in the water phase represents all the me/aboti/es synthesized
le vitro. While kss sensitive than the more commonly used fluorimelric method.
Ihis new Iechnique, whose lower limit of sensitivity is estimated to be about
2.10 'r moks of total metaboliles formcd /ml Incubalhm medium, Is es-
Iremely accurale, can measure eaRahepalie and low AIIII aclivi/y, and is not
particularly photosensitive.
Van Canlforl, 1., De Oraeve. 1. and Glrfrn, !. F,.
eiochemtcaJ ond BJoph yrka/ Research Commynications 79( 2): S0S-f 1 Z, 1977.
From the I ahoratoire dc ('himie MtdiLale, Inslitul de Pathologie. Sart lilman
par 1.it2e. Belarum.
12 1 )

COMPARISON OF ARYL HYDROCARBON HYDROXYLASE
INDUCTION IN CULTURED BLOOD LYMPHOCYTF.S AND
PULMONARY MACROPHAOES
In this study. !n vitro ioducibility of aryl hydrocarbon hydroaylase (AHH)
in freshly lavaged pulmonary alveolar aucrophaRea (PAM) was compared to the
degree of induction of Atilt in cultured lymphocytes from 13 smokers and t
nonsmokers with a.ariety of noooeoplaMie lung disenes. Values obtained
for Atilt in PAMs and in lymphocytes from patients withio the rwnsmoker
and smoker groups were similar. Levais of AHH in PAMa freshly obtained
by lavare were higher for smoken thao for rwnsmoken. With PAMs from
sonamokers, bvels of Atilt were virtually Identical for celts cultured for
24 hrs. with so inducer in the medium and for cells freshly lavaged from the
lun6 In eontrut, values for PAMs from anakers were reduced to about half
the original kvels after culture (or 24 hn. with no inducer in the medium.
Atilt values were similar when noninduced enzyme levels were compared for
nonsmoker or smoker PAMs and lymphocytes. Also, when PAMs and lympho-
cytes from smokers or nonsmokers were cultured In the presence of BA,
similar enzyme induction was observed. Results from these studieo indicate
that Atilt levels in one cell type can accurately reflect levels measured in the
other cell type. Howevet, cigarette smoking dfeets the noninduced as well as
the BA-induced levels of the eozyme. This is the first dme that celh (rom two
scparsle tissues from Individusl subjecti have been shown to possess similar
Atilt Induction capabilities when tested under Identical tulture conditions.
By measuring Atilt in two separate tiawes from the same irdividual, probkms
previously encountered in using a single tissue for analysis of an individual'a
Atilt characterislics might he resolved. This added dimension for the analysis
of Atilt in individuals might also provide reaearchers with another tool for
evaluating the relationship of Atilt to chemical carcinotenesis.
Mcl.emore, T. L., Afarrin, R. R., Toppell, K. L., Busbee, D. L, and Cantrell,
1'. T.
The /orrnal of CNnlcaf Inrttrltarlon 60:1017-1021, 1977.
Ot6er support: Nationa11ns1itutesof Health.
From the Department of Medicine and the Department of Microb:iloty and
Immunology. Baylor College of Medicine. Houston; and the Department of
BioNogical Sciences. North Tezas Stak Univenity, Denton.
ANALYSIS OF ARYI. HYDR(X'ARBON NYDROXYI.ASN A('1'1% 11 Y
IN 11l/MAN l.l/N(3 TISSUE. PULMONARY MAC'ROPIIA(iES
ANI) B1.CX)1) t.YMPHOCYT['S
While variation In the degree of aryl hydrocarbon hydroaylasc (Atlli)
inducil+ildy has been observed in pulmonary alveolar macrophases (PAM)
and IympMrcylcs lrom diRcrrnl individusls. AHII values in these cclls have
aN hrrn relaled w the A1111 s.hvory in other urlulosous titaues In this
ahmJy d~r 1111/ ay i..*ty m t.c.h au-tually rrcised Iunif Wiue. Iresh PAM
I
i
I
and peripheral bl.od lymphocytes from 14 ciprette smoken (7 with untreated
primary lung cancer and 7 eoncancer p.tienu), was measured fluorometrically.
Individuals without cancer showed a good correlation (r = 0.973, p<.001)
between the PAM's AHH levels and the AIIH inducibility (ezprea.ed as lob
induction) in their cultured, mitogen-atirnulated lymphocytea. In the canox
patient., however, these values were diaocialed. In addition, the fresh lung
tissue Atilt levels and the cultured lymphocytes' fold-inductioo ratioe eorre-
lated positively in noncancer patients but oot in the cancer patients. 7lhere was
close agreement between fresh lung tissue Atilt and fresh PAM from iodi-
vidual cancer-(roe palients, but theae values were only weakly correlated in
those with cancer. Upon simuluneous comparison of Atilt activity in fresh
PAM and in fresh lung tissue, and AHII inducibility in cultured lymphocytn,
an ezcelknt rclalionship was found between these values in all three tissues
for individual noncancer paliems (r = 0.987, p<.001). Ilowevcr, thc.e did
not correlate in Individual lung cancer patients According to the data, while
the capacity for Atilt induction in eaneer-free cigarette smokers is similar
in the tiuues qudied. h+nR cancer patients do not have positively correlated
Atilt valuea in these tiawes.
Mcl.emore, T. L., Afan/n. R. R., Pickard, L. R., Springer. R. R.. Wray, N. P.,
Toppell, K. L., Matwz, K. L., Guinn, 0. A., Cantrell, @. T., and Busbee, D. L.
Cancrr 11(6):2292-2700, 1978.
OtAer wpportr National Institutea of Ilealth, National Cancer Institute and
the American Cancer Society.
From the Deparimenb of Medicine and S1srRery, Baylor College of Medicir
and Veterans Adminiuration Ho.pilal, Houston; and the 1)epartmeot of
Biological Sciences, North Team State Univenity, Denton.
DISSOCIATION BETWEEN ARIL HYDROCARBON IIYDROXYLASH
ACTIVITY IN CULTURED PULMONARY MACROPHAGES AND
BLOOD LYMPIIOCYTES FROM LUNO CANCER PATIQNTS
Lymphocytes and pulmonary alveolar maeropha6es ( PAM ) used foe
evaluation of aryl hydrocarbon hydroaylase (AHII) induction were oblalned
trorn 13 noncancer and 14 primary lung cancer patients. Fnzyme levels wera
mcawred in cells cultured with or withoul the inducer benzanlhraeene (BA).
7Le mean levels of AIIH showed no diQerence belween noncancer and caawr
patients for either noninduced or BA-induced cells. Absolute kvels and foid
induction of Alll1 in PAM and lymphocyka from Individual noncancer
patients were positively correlated. Ilowever, comparison of these values i.
PAM and lymphocytes frrom individual lung cancer p.tients demonstrated no
positive correlation. In further study, comparison of enzyme activity io macro-
phages fr~eahly lavaged from the lung and BA-induced activity in cultured
PAM revealed a positive correlation (or both noncancer and lung cancer p.-
licnts. Similarly, comparison of eozyme activity in fresh macrophagcs and told
induction values in cultured PAM was also well correlated frw M.th groups of
patients From these sludies. it would appear that messuiement of Atilt In
more than one tissue obtained on the sanme day from a given individual may
1A . IS
